591 therapy is a given.14 months survival in ph2 compared to 5 with Pluvicto and less side affects than Pluvicto.Surprised Novartis has not put a bid in for Telix
Ann: Telix 2023 Full Year Results and Investor Webcast/Call, page-119
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add TLX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$19.00 |
Change
0.590(3.20%) |
Mkt cap ! $6.323B | |||
| Open | High | Low | Value | Volume |
| $18.85 | $19.17 | $18.78 | $8.857M | 466.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 327 | $18.99 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $19.01 | 2286 | 16 |
View Market Depth
| Last trade - 13.10pm 16/08/2024 (20 minute delay) ? |
| TLX (ASX) Chart |